Tirofiban Hydrochloride Injection
Indication
It is suitable for patients with unstable angina or non-Q wave myocardial infarction to prevent cardiac ischemic events. It is also suitable for patients with coronary ischemic syndrome undergoing coronary angioplasty or intracoronary plaque resection to prevent cardiac ischemic complications related to sudden occlusion of treated coronary arteries.
Packaging Specification
50ml:12.5mg (based on tirofiban)
Manufacturer
Lunan BETTER Pharmaceutical Co., Ltd.
-
Founded in:
2003-12-16 -
Address:
No. 209, Hongqi Road, Linyi City -
Tax NO.:
91371300756399007K -
Registered Funds:
115 million yuan -
Website:
-
Email: